New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances

被引:31
作者
Hunfeld, KP [1 ]
Kraiczy, P [1 ]
Wichelhaus, TA [1 ]
Schäfer, V [1 ]
Brade, V [1 ]
机构
[1] Univ Hosp Frankfurt, Inst Med Microbiol, D-60596 Frankfurt, Germany
关键词
D O I
10.1007/s100960050005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A newly developed colorimetric microdilution method was used to analyze the activity of 12 antimicrobial agents against nine Borrelia burgdorferi isolates, including all three genospecies pathogenic for humans. In addition, in vitro antimicrobial resistance patterns of Borrelia valaisiana and Borrelia bissettii tick isolates were investigated. The applied test system is based upon color changes that occur in the presence of phenol red and result from the accumulation of nonvolatile acid produced by actively metabolizing spirochetes. After 72 h of incubation, minimal inhibitory concentrations (MICs) were determined from the decrease of absorbance by software-assisted calculation of growth curves. MIC values were lowest for azlocillin (MIC, less than or equal to 0.125 mu g/ml), ceftriaxone (MIC range, less than or equal to 0.015-0.06 mu g/ml), and azithromycin (MIC range, less than or equal to 0.015-0.06 mu g/ml). Whereas tobramycin (MIC range, 8-64 mu g/ml) exhibited little activity, spectinomycin (MIC range, 0.25-2 mu g/ml) showed in vitro antimicrobial activity against Borrelia burgdorferi. The MICs of penicillin G for Borrelia afzelii isolates were ten times higher than those for Borrelia burgdorferi, Borrelia valaisiana, and Borrelia bissettii isolates (P<0.05) and 100 times higher than those for isolates belonging to the genospecies Borrelia garinii (P<0.05). Further significant differences with respect to the MIC values of the other antimicrobial agents tested were not noted. The colorimetric microdilution method offered the advantages of reliability, reproducibility, and convenience and could handle large numbers of isolates and antibiotics.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 24 条
[1]   INVITRO SUSCEPTIBILITIES OF BORRELIA-BURGDORFERI TO 5 ORAL CEPHALOSPORINS AND CEFTRIAXONE [J].
AGGER, WA ;
CALLISTER, SM ;
JOBE, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1788-1790
[2]  
BaradaranDilmaghani R, 1996, INFECTION, V24, P60, DOI 10.1007/BF01780660
[3]   GENOMIC FINGERPRINTING OF BORRELIA-BURGDORFERI SENSU-LATO BY PULSED-FIELD GEL-ELECTROPHORESIS [J].
BELFAIZA, J ;
POSTIC, D ;
BELLENGER, E ;
BARANTON, G ;
STGIRONS, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (11) :2873-2877
[4]  
BOERNER J, 1995, ZBL BAKT-INT J MED M, V283, P49
[5]   COMPARATIVE IN-VITRO ACTIVITIES OF CLARITHROMYCIN, AZITHROMYCIN, AND ERYTHROMYCIN AGAINST BORRELIA-BURGDORFERI [J].
DEVER, LL ;
JORGENSEN, JH ;
BARBOUR, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1704-1706
[6]   INVITRO ANTIMICROBIAL SUSCEPTIBILITY TESTING OF BORRELIA-BURGDORFERI - A MICRODILUTION MIC METHOD AND TIME-KILL STUDIES [J].
DEVER, LL ;
JORGENSEN, JH ;
BARBOUR, AG .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (10) :2692-2697
[7]   INVITRO ACTIVITY OF VANCOMYCIN AGAINST THE SPIROCHETE BORRELIA-BURGDORFERI [J].
DEVER, LL ;
JORGENSEN, JH ;
BARBOUR, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1115-1121
[8]   In vitro susceptibility testing of Borrelia burgdorferi by a dialysis culture method [J].
Dever, LL ;
Jorgensen, JH ;
Barbour, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1208-1208
[9]   PREVALENCE OF TICK-BORNE ENCEPHALITIS AND LYME BORRELIOSIS IN A DEFINED SWEDISH POPULATION [J].
GUSTAFSON, R ;
SVENUNGSSON, B ;
GARDULF, A ;
STIERNSTEDT, G ;
FORSGREN, M .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1990, 22 (03) :297-306
[10]  
HANSEN K, 1992, ACTA DERM-VENEREOL, V72, P297